Market News & Trends
GW Pharmaceuticals Achieves Positive Results in Phase II Study
GW Pharmaceuticals plc recently announced positive top-line results from an exploratory Phase II placebo-controlled clinical study of a proprietary combination of tetrahydrocannabinol (THC) and cannabidiol…
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.…
Galectin Presents Clinical Data of Combination Immunotherapy With Galectin-3 Inhibitor GR-MD-02
Galectin Therapeutics Inc. and the Providence Cancer Center recently announced the presentation of preclinical and early clinical data from two investigator-initiated Phase I clinical trials…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
Next-Generation Silicone Adhesive Technologies Key to Broader Global Adoption, Growth of Wearable Medical Devices
According to Grand View Research, the global market for wearable medical devices is expected to reach $27.8 billion by 2022.1 Dow Corning, a global leader…
Abeona Therapeutics Enrolls First High-Dose Subject in Ongoing Phase I/II Trial
Abeona Therapeutics Inc. recently announced that the first high-dose subject was enrolled in the ongoing Phase I/II trial for ABO-102 (AAV-SGSH). The first-in-man clinical trial…
Advaxis’ GOG-0265 Study in Metastatic Cervical Cancer Selected for Late-Breaking Data Presentation
Advaxis, Inc. recently announced that an abstract on data from the company’s Phase II GOG-0265 trial evaluating axalimogene filolisbac for metastatic cervical cancer has been…
Gerresheimer Optimizes Cold-End Operations at its Pharma Glass Production Plants With State-of-the-Art Packing Robots
Every year, Gerresheimer’s pharmaceutical industry customers order several hundreds of millions of glass pharmaceutical packaging products manufactured at the company’s plants in Essen and Lohr.…
Incyte & Calithera Biosciences Announce Global Collaboration
Incyte Corporation and Calithera Biosciences, Inc. recently announced the companies have entered into a global collaboration and license agreement for the research, development, and commercialization…
Gemphire Announces Interim LDL-C Lowering Data From Clinical Trial
Gemphire Therapeutics Inc. recently announced interim data on the LDL-C primary endpoint from the ongoing open label COBALT-1 trial. COBALT-1 is investigating gemcabene in homozygous familial…
First Clinical Milestone Achieved in Collaboration Between AbCheck & Lilly
AbCheck s.r.o., a technology company focusing on the discovery and optimization of high-quality human antibodies, recently announced the achievement of the first clinical milestone in…
SiO2 Medical Products, Inc. Receives Marketing Authorization for Filled 6-mL Vials
SiO2 Medical Products, Inc. (SMP) received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines…
Patheon Announces Completion of its Acquisition of State-of-the-Art Manufacturing Site
Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed…
SiO2 Medical Products, Inc. Receives Marketing Authorization for Filled 6-mL Vials
SiO2 Medical Products, Inc. (SMP) received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines…
Patheon Announces Completion of its Acquisition of State-of-the-Art Manufacturing Site
Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed…
West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at Pharmapack Europe 2017. The LyoSeal…
West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at Pharmapack Europe 2017. The LyoSeal…
